CFO
HALO icon

Collective Family Office’s Halozyme HALO Stock Holding History

Collective Family Office’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Buy
8,113
+1,008
+14% +$68.7K 0.13% 105
2026
Q1 		$459K Buy
7,105
+2,298
+48% +$162K 0.1% 112
2025
Q4 		$324K Buy
+4,807
New +$323K 0.07% 132

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Collective Family Office's HALO Position: Q2 2026 in Review

Collective Family Office increased its Halozyme (HALO) stake by 14% in Q2 2026, buying an estimated $68.7K and bringing the position to 8,113 shares worth $635K. The position accounts for 0.13% of the portfolio, ranked #105.

Collective Family Office first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Collective Family Office held 8,113 shares of Halozyme worth $635K as of Q2 2026.
  • Collective Family Office bought 1,008 Halozyme shares in Q2 2026, an estimated $68.7K.
  • Halozyme made up 0.13% of Collective Family Office's portfolio in Q2 2026, its #105 holding.
  • Collective Family Office first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Collective Family Office's 13F filing for Q2 2026, filed 2 Jul 2026.